Presentation Title
The Use of Beers List Medication in Patients 40-64 Years Old Compared to Patients 65 and Older
Presenter Credentials
College of Pharmacy, third year, Pharm.D. College of Pharmacy, third year, Pharm.D. College of Pharmacy, third year, Pharm.D.
Presenter Degree
PharmD
College
College of Pharmacy
Campus Location
Ft. Lauderdale
Format
Poster
IRB Approval Verification
N/A
Abstract
Purpose The purpose of this is study is to evaluate the use of Beers list drugs among adults 40-64 and 65 years and older and to evaluate the use of Beers list drug use and healthcare use in those over 65. Background Inappropriate prescribing of the Beers list medications, published by the American Geriatric Society, has been associated with an increased risk of hospitalization and mortality. Potential harm from these agents includes increased fall risk and mortality. Studies have documented how often inappropriate medications have been prescribed and their potential adverse events in the geriatric population; however, no national studies have evaluated the association of Beers list drug use and healthcare use. Methods This study was an observational cohort study using data from the National Health and Nutrition Examination Survey (NHANES) cohort years 2013-2014, 2015-2016, and 2017-2018. The primary exposure-outcome was the use of Beers list medications. Factors of interest were whether participants received healthcare over the past year, had overnight hospital visits in the past year, and if they had health insurance. Uni- and multivariable logistic regression models evaluated the association of Beers list use and healthcare use. Crude and adjusted odds ratio with a 95% CI and an alpha level of 5% was used. IBM SPSS version 27 was utilized. Results The final cohort included 11,463 survey participants, with 4,184 (29.0%) participants 65 years or older on at least one Beers list drug versus 20.7% of those 40-64, (p= Conclusion A positive association of Beers list drug use in those over 65 years old and healthcare use was found in this study. Controlling demographic predictors made a small impact on their association. Additional Beers list drugs may be prescribed to the geriatric population in addition to those already being used at an earlier age. Longitudinal studies should evaluate the causal-effect relation of Beers list drug use and healthcare use.
Selection Criteria
1
The Use of Beers List Medication in Patients 65 and Older and Their Association with Healthcare Use
The Use of Beers List Medication in Patients 40-64 Years Old Compared to Patients 65 and Older
Purpose The purpose of this is study is to evaluate the use of Beers list drugs among adults 40-64 and 65 years and older and to evaluate the use of Beers list drug use and healthcare use in those over 65. Background Inappropriate prescribing of the Beers list medications, published by the American Geriatric Society, has been associated with an increased risk of hospitalization and mortality. Potential harm from these agents includes increased fall risk and mortality. Studies have documented how often inappropriate medications have been prescribed and their potential adverse events in the geriatric population; however, no national studies have evaluated the association of Beers list drug use and healthcare use. Methods This study was an observational cohort study using data from the National Health and Nutrition Examination Survey (NHANES) cohort years 2013-2014, 2015-2016, and 2017-2018. The primary exposure-outcome was the use of Beers list medications. Factors of interest were whether participants received healthcare over the past year, had overnight hospital visits in the past year, and if they had health insurance. Uni- and multivariable logistic regression models evaluated the association of Beers list use and healthcare use. Crude and adjusted odds ratio with a 95% CI and an alpha level of 5% was used. IBM SPSS version 27 was utilized. Results The final cohort included 11,463 survey participants, with 4,184 (29.0%) participants 65 years or older on at least one Beers list drug versus 20.7% of those 40-64, (p= Conclusion A positive association of Beers list drug use in those over 65 years old and healthcare use was found in this study. Controlling demographic predictors made a small impact on their association. Additional Beers list drugs may be prescribed to the geriatric population in addition to those already being used at an earlier age. Longitudinal studies should evaluate the causal-effect relation of Beers list drug use and healthcare use.